Monday, June 27, 2016

ZIOPHARM Completes Enrollment in Second Patient Cohort and Initiates Enrollment in Third Cohort in Phase 1 Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer

… 1 study of Ad-RTS-hIL-12 in brain cancer at future scientific meetings. All …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)